← Back to Clinical Trials
Recruiting NCT07494149

NCT07494149 Group-Based Exercise Intervention to Prevent Cognitive and Motor Decline

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07494149
Status Recruiting
Phase
Sponsor University of Bergamo
Condition Healthy
Study Type INTERVENTIONAL
Enrollment 158 participants
Start Date 2026-02-01
Primary Completion 2026-07

Eligibility & Interventions

Sex All sexes
Min Age 50 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
IdeomotorControl

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 158 participants in total. It began in 2026-02-01 with a primary completion date of 2026-07.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to evaluate the efficacy of the Ideomotor Program in healthy older adults living in the community. The main research questions are: 1\) Is the Ideomotor Program effective in improving cognitive function? 2) Is the Ideomotor Program effective in improving motor function? 3) Is the Ideomotor Program effective in improving overall well-being? Researchers will compare the Ideomotor Program to a community group cognitive training program to determine whether the effects are superior. Participants will: undergo assessments at baseline, at the mid-intervention point, and upon program completion; participate in a 16-week group exercise program in a community gym two times per week; keep a diary to monitor the number of falls and any adverse events.

Eligibility Criteria

Inclusion Criteria: * At least 50 years old; * Able to move independently; * Live in the community; * Demonstrated ability to comprehend complex verbal instructions. Exclusion Criteria: * Presence of severe neurological and psychological conditions; * Less than 9,36 score in the FAB15; * Lack of medical clearance to participate in an exercise program; * Less than 75% of attendance.

Contact & Investigator

Central Contact

Inaihá L. Benincá, PhD student

✉ inaiha.laureanobeninca@unibg.it

📞 +39 0352052960

Frequently Asked Questions

Who can join the NCT07494149 clinical trial?

This trial is open to participants of all sexes, aged 50 Years or older, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07494149 currently recruiting?

Yes, NCT07494149 is actively recruiting participants. Contact the research team at inaiha.laureanobeninca@unibg.it for enrollment information.

Where is the NCT07494149 trial being conducted?

This trial is being conducted at Bergamo, Italy, Bergamo, Italy.

Who is sponsoring the NCT07494149 clinical trial?

NCT07494149 is sponsored by University of Bergamo. The trial plans to enroll 158 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology